Ro GLP-1 Cost: What Tirzepatide and Semaglutide Actually Run Each Month

The quick answer: what Ro Body actually costs

Ro charges two separate bills every month: a membership fee and a medication fee. The membership runs $39 for month one, then $149 per month ongoing — or as low as $74 per month if you prepay an annual plan. Medication is billed on top of that, at prices set by the manufacturer and Ro's LillyDirect and Novo Nordisk partnerships. Cash-paying patients on tirzepatide typically land between $548 and $598 per month all-in. Those using insurance can reduce that sharply, sometimes to just their copay.

• Membership: $39 first month, $149/mo ongoing (or $74/mo on annual prepay)
• Zepbound tirzepatide: $299 first month, then $399–$449/mo by dose
• Wegovy pill (oral semaglutide): $149 first month, then $199–$299/mo
• Wegovy pen (injectable semaglutide): $199 first month, then up to $399/mo
• Shipping: included on all medications
• Labs: included when clinically required

How much is tirzepatide through Ro — every dose tier

Ro dispenses Zepbound KwikPens and single-dose vials through its LillyDirect integration, which means the medication prices mirror Eli Lilly's own cash-pay program. Dose determines cost: the 2.5 mg starter dose costs $299 for the first month, the 5 mg dose rises to $399 per month, and every higher maintenance dose — 7.5 mg through 15 mg — costs $449 per month. Add the $149 membership and a patient titrating up to a therapeutic maintenance dose pays roughly $598 per month once they pass the introductory tier.

The dose-escalation schedule matters here. Most patients spend one to three months at each dose level before their provider adjusts upward. A typical first year therefore blends lower-dose months early on with higher-dose months as tolerance builds — meaning your average monthly spend likely falls between the floor and the ceiling rather than sitting at the maximum from day one.

How much is semaglutide through Ro

Ro offers two semaglutide formats, which affects both price and experience. The Wegovy pill — oral semaglutide, FDA-approved in December 2025 and launched through Ro in January 2026 — starts at $149 for the first month, then runs $199 to $299 per month at higher doses. The Wegovy injectable pen starts at $199 for the first month and can reach $399 per month at upper dose levels, though Ro has run promotional pricing at $199 for the lower 0.25 mg and 0.5 mg doses. Both formats require the $149 monthly membership on top.

One shift worth noting: Ro no longer offers compounded semaglutide. After the FDA declared the semaglutide shortage resolved in early 2025 and followed with enforcement actions against compounding platforms through 2026, Ro moved entirely to FDA-approved brand-name medications. Patients who want lower-cost compounded versions will need to look elsewhere.

What is Ro Body's membership fee — and what does it actually cover?

The $149 monthly membership is not a consulting fee for a single visit. It covers a meaningful bundle of ongoing services: a personalized treatment plan, unlimited 1:1 provider messaging, regular check-in visits, metabolic health coaching, and Ro's insurance concierge — a team that handles prior authorizations, appeals, and the paperwork burden of getting insurance to cover brand-name GLP-1s. Lab testing is included when a provider orders it as clinically necessary.

The annual prepay option brings the membership down to $74 per month, saving roughly $900 over twelve months compared to rolling monthly billing. That rate applies to the membership only; medication is still billed separately at the same per-dose price.

• Unlimited provider messaging: included
• Regular check-in visits: included (up to 24 per year; $15 each thereafter)
• Metabolic health coaching: included
• Insurance prior authorization support: included
• Lab testing when clinically required: included
• Shipping on all medications: included
• Medicare/Medicaid coordination: not available

Hidden fees and what to watch for before you sign up

The dual-billing structure is the most common source of frustration in Ro reviews. The first-month membership fee — currently $39 — is non-refundable even if you are not approved for treatment after your medical evaluation. Some users report confusion when they discover the advertised starting price covers only the membership, not the medication that arrives separately on a second invoice.

• Non-refundable first-month membership fee ($39) applies whether or not you are approved
• Medication and membership are billed on separate invoices, which surprises some members
• After 24 provider consultations per year, additional visits cost $15 each
• Lab fees beyond what is clinically required may carry separate charges
• Amounts paid do not count toward your insurance deductible or out-of-pocket maximum
• Cancellation requires contacting support — there is no self-service cancel button
• 48-hour advance notice required to avoid renewal charge

None of these are dealbreakers on their own, but knowing them before you enter a credit card prevents the surprise that drives a significant share of negative Trustpilot reviews. Ro holds a 3.7 out of 5 on Trustpilot across more than 3,100 reviews as of June 2026, with a B rating from the BBB and a notably higher 4.4 out of 5 on ConsumerAffairs — the variance reflects how billing frustrations and customer service experiences skew review platforms differently from clinical outcomes.

What does a full year of Ro tirzepatide cost? The annual estimate

Running the math on a typical tirzepatide patient paying cash: month one costs $448 ($299 medication + $149 membership). A patient who escalates to the 5 mg dose by month three and reaches a maintenance dose of 10 mg or higher by month six would pay $399 per month for a few months and $449 per month at higher doses, always with the $149 membership on top. A realistic full-year total for a cash-paying patient on Zepbound through Ro lands between roughly $6,600 and $7,900 depending on dose progression — call it approximately $7,200 per year as a midpoint estimate.

The oral Wegovy path is meaningfully cheaper at cash pay. A patient starting at $149 per month for the pill and rising to $299 at higher doses, plus the $149 membership, puts the annual total somewhere between $4,000 and $5,400 — a more approachable number for patients without insurance coverage.

With insurance, the picture changes entirely. Ro's insurance concierge is one of its stronger differentiators: if your plan covers Wegovy or Zepbound, you may pay only your copay, often $25 to $50 per month, with the membership as the primary out-of-pocket cost. That scenario brings total annual spending down to roughly $2,000 to $2,700 per year — a very different equation from the cash-pay numbers.

How Ro GLP-1 pricing compares to competitors

Ro's main differentiator is FDA-approved medications with an integrated insurance concierge. That combination makes it competitive for insured patients but premium-priced for those paying out of pocket. Here is how the cash-pay math compares across platforms commonly considered alongside Ro.

• Ro (tirzepatide, cash pay): ~$548–$598/mo all-in (Zepbound KwikPen + $149 membership)
• Ro (oral semaglutide, cash pay): ~$298–$448/mo all-in (Wegovy pill + $149 membership)
• Mochi Health (compounded tirzepatide): ~$278/mo all-in ($199 medication + $79 membership), flat rate at all doses
• Mochi Health (compounded semaglutide): ~$178/mo all-in ($99 medication + $79 membership)
• Hers (brand Wegovy/Zepbound): ~$298–$448/mo all-in (Hers stopped advertised compounded in 2026)
• Fridays (compounded tirzepatide): ~$240–$359/mo depending on supply length purchased

The gap between Ro and compounded-GLP-1 platforms is real, but the context matters. Ro's medications are FDA-approved brand names dispensed through licensed pharmacies with manufacturer quality controls. Compounded GLP-1s from 503A and 503B facilities carry a different regulatory status — they are not FDA-approved as finished drug products, and the legal landscape for compounding has narrowed significantly in 2026. For patients who specifically want Zepbound or Wegovy rather than a compounded equivalent, Ro's pricing is in line with what Eli Lilly and Novo Nordisk charge through their own direct programs.

For a fuller look at how competitors structure their programs, see the Mochi Health review, the Hers review, and the Fridays review.

Is Ro GLP-1 worth the cost? Who it's built for

Ro's pricing structure makes most sense in two scenarios. The first is patients with commercial insurance that covers Wegovy or Zepbound: Ro's insurance concierge does the heavy lifting on prior authorization, and if coverage comes through, the membership fee becomes a reasonable price for ongoing clinical support. The second is patients who specifically want FDA-approved brand-name medication and the accountability structure of a formal program — coaching, regular check-ins, and a provider in their corner.

Cash-paying patients who simply want the lowest monthly bill for a compounded GLP-1 will find better numbers at platforms like Mochi Health or Fridays. And patients on Medicare or Medicaid should know upfront that Ro cannot coordinate those government insurance plans.

The program is also a reasonable fit for women in perimenopause and menopause who are navigating GLP-1s for the first time and want the reassurance of a well-known platform with documented clinical staff and FDA-approved medications — even if that reassurance comes at a price premium over compounded alternatives. Ro has operated since 2017, which gives it a longer track record than many newer entrants.

Current promotions and ways to lower the cost

Ro runs periodic promotional pricing on Wegovy. As of early 2026, the injectable pen was available at $199 per month for the 0.25 mg and 0.5 mg doses, described as a promotional rate. Promotional windows shift; the pricing page at ro.co is the reliable source for what is currently active.

The Prepay and Save plan cuts the membership cost to $74 per month — a $900 annual saving versus monthly billing. Combining the prepay membership with a lower-dose medication tier is the most straightforward way to reduce Ro's all-in cost without switching platforms. FSA and HSA funds can also be used toward membership and medication costs, which effectively reduces out-of-pocket for patients with funded accounts.

• Prepay annual membership: $74/mo (saves $900/yr vs monthly)
• Wegovy pen promotional pricing: $199/mo for starter doses (confirm current dates)
• Insurance concierge: can reduce medication cost to copay only if covered
• FSA/HSA: eligible for both membership and medication costs